Skip to content
10-Q

Quarterly Report

RIGEL PHARMACEUTICALS INC RIGL

0001104659-25-106268

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 18.15M sh
Shares Diluted Q3 2025 · Sep 30, 2025 19.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 18.38M sh
Shares Diluted Q3 2025 · Sep 30, 2024 17.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 17.6M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 $53.68M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $16.97M
Long Term Debt Q3 2025 · Sep 30, 2025 $60M
Short Term Investments Q3 2025 · Sep 30, 2025 $88.61M
Short Term Investments Q3 2025 · Dec 31, 2024 $20.58M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $48.53M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $56.75M
Stockholders Equity Q3 2025 · Sep 30, 2025 $117.61M
Stockholders Equity Q3 2025 · Jun 30, 2025 $81.93M
Stockholders Equity Q3 2025 · Mar 31, 2025 $18.57M
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.29M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$14.64M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$29.91M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$31.67M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$28.64M
Current Liabilities Q3 2025 · Sep 30, 2025 $94.4M
Current Liabilities Q3 2025 · Dec 31, 2024 $63.3M
Total Liabilities Q3 2025 · Sep 30, 2025 $124.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $160.69M
Current Assets Q3 2025 · Sep 30, 2025 $214.93M
Current Assets Q3 2025 · Dec 31, 2024 $135.1M
Total Assets Q3 2025 · Sep 30, 2025 $242.53M
Total Assets Q3 2025 · Dec 31, 2024 $163.98M
Eps Diluted Q3 2025 · Sep 30, 2025 $1.46
Eps Diluted Q3 2025 · Sep 30, 2025 $5.38
Eps Diluted Q3 2025 · Sep 30, 2024 $0.70
Eps Diluted Q3 2025 · Sep 30, 2024 $0.18
Eps Basic Q3 2025 · Sep 30, 2025 $1.55
Eps Basic Q3 2025 · Sep 30, 2025 $5.52
Eps Basic Q3 2025 · Sep 30, 2024 $0.71
Eps Basic Q3 2025 · Sep 30, 2024 $0.18
Sga Expense Q3 2025 · Sep 30, 2025 $28.94M
Sga Expense Q3 2025 · Sep 30, 2025 $85.91M
Sga Expense Q3 2025 · Sep 30, 2024 $27.04M
Sga Expense Q3 2025 · Sep 30, 2024 $83.54M
Net Income Q3 2025 · Sep 30, 2025 $27.9M
Net Income Q3 2025 · Sep 30, 2025 $98.96M
Net Income Q3 2025 · Sep 30, 2024 $12.42M
Net Income Q3 2025 · Sep 30, 2024 $3.14M
Operating Income Q3 2025 · Sep 30, 2025 $28.42M
Operating Income Q3 2025 · Sep 30, 2025 $102.3M
Operating Income Q3 2025 · Sep 30, 2024 $14.06M
Operating Income Q3 2025 · Sep 30, 2024 $7.54M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $4.75M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $13.67M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $8.03M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $12.86M
Revenue Q3 2025 · Sep 30, 2025 $69.46M
Revenue Q3 2025 · Sep 30, 2025 $224.48M
Revenue Q3 2025 · Sep 30, 2024 $55.31M
Revenue Q3 2025 · Sep 30, 2024 $121.68M